Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
cancer
6
×
boston blog main
boston top stories
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
europe blog main
europe top stories
startups
deals
drugs
eli lilly
genentech
investing
novartis
otsuka pharmaceutical
What
fda
6
×
bio
cancer
drug
roundup
approved
medicines
activity
address
age
ahead
approval
approvals
approves
asco
biogen
blueprint
branded
carries
certain
choices
clamped
commissioner
companies
consumers
costly
counterweight
covid
delays
designed
developing
digital
disease
drugs
economic
eisai
elevatebio
epidemic
fast
fatty
Language
unset
Current search:
biotech
×
cancer
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@extremetech.com
8 years ago
First cancer-killing virus finally approved by FDA
